# TransMedics Group, Inc. (TMDX) FY2026 Q2 Balance Sheet

- Company: TransMedics Group, Inc. (TMDX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001193125-26-332843
- Page: https://plicit.ai/financials/tmdx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/tmdx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,464,396,000 US dollars
- **Current assets**: 651,124,000 US dollars
- **Non-current assets**: 813,272,000 US dollars
- **Liabilities**: 946,343,000 US dollars
- **Current liabilities**: 98,283,000 US dollars
- **Non-current liabilities**: 848,060,000 US dollars
- **Equity**: 518,053,000 US dollars
- **Cash**: 472,675,000 US dollars
- **Accounts receivable**: 104,138,000 US dollars
- **Inventory**: 54,137,000 US dollars
- **Prepaid expenses and other current assets**: 20,174,000 US dollars
- **Property, plant and equipment, net**: 365,302,000 US dollars
- **Finance lease right-of-use assets, net**: 332,472,000 US dollars
- **Deferred tax assets**: 78,677,000 US dollars
- **Restricted cash**: 18,438,000 US dollars
- **Goodwill**: 11,549,000 US dollars
- **Operating lease right-of-use assets, net**: 4,646,000 US dollars
- **Other non-current assets**: 2,188,000 US dollars
- **Acquired intangible assets, net**: 0 US dollars
- **Accrued expenses and other current liabilities**: 58,598,000 US dollars
- **Current portion of long-term debt**: 20,000,000 US dollars
- **Accounts payable**: 12,909,000 US dollars
- **Operating lease liabilities**: 3,646,000 US dollars
- **Deferred revenue**: 3,130,000 US dollars
- **Convertible senior notes, net**: 454,260,000 US dollars
- **Finance lease liability**: 347,660,000 US dollars
- **Long-term debt, net**: 39,743,000 US dollars
- **Other long-term liabilities**: 3,986,000 US dollars
- **Operating lease liabilities, net of current portion**: 2,411,000 US dollars
- **Common stock, no par value; 150,000,000 shares authorized; 34,629,682 shares and 34,267,802 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 774,216,000 US dollars
- **Accumulated deficit**: negative 255,953,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 210,000 US dollars
- **Gross equity (calculated)**: 774,216,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.